Efficacy of intramuscular diclofenac and fluid replacement in prevention of post-ERCP pancreatitis

Table 2 Incidence of post-ERCP pacreatitis in different subgroups¹

	Diclofenac group (n = 40)	Control group (n = 40)	P
Variables
Age group (yr)
> 60	2/23	4/20	0.300
≤ 60	1/17	3/20	0.420
Sex
Male	0/25	2/18	0.850
Female	3/15	5/22	0.092
Pre-cut sphincterotomy
Yes	1/10	4/12	0.210
No	2/30	3/28	0.590
Pancreatic duct injection
Yes	2/19	4/18	0.350
No	1/21	3/22	0.330
Pancreatic duct cannulation, twice or more	2/8	1/6	0.730
SOD
Yes	2/3	2/10	0.150
No	1/37	5/30	0.0471

¹All data were comparisons with the χ² test. There were no statistically significant differences except in the patients without SOD.